المؤلفون: Chua MLK; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore.; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Hakansson AK; Veracyte, Inc, San Diego, CA, USA., Ong EHW; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Hong BH; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Miao JJ; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.; Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China., Sim AYL; Duke-NUS Medical School, Singapore, Singapore.; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Tan JSH; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore., Tan KM; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Lee GCJ; Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria, Australia., Low KP; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Tuan JKL; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Tan TWK; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Wang MLC; Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Yeong JPS; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore., Tan MCS; Department of Pathology, Changi General Hospital, Singapore, Singapore., Lee LS; Duke-NUS Medical School, Singapore, Singapore.; Department of Urology, Sengkang General Hospital, Singapore, Singapore., Kanesvaran R; Duke-NUS Medical School, Singapore, Singapore.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Zhao X; Veracyte, Inc, San Diego, CA, USA., Ho J; Veracyte, Inc, San Diego, CA, USA., Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA., Schaeffer EM; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Tay KJ; Duke-NUS Medical School, Singapore, Singapore.; Department of Urology, Singapore General Hospital, Singapore, Singapore., Liu Y; Veracyte, Inc, San Diego, CA, USA., Davicioni E; Veracyte, Inc, San Diego, CA, USA., Khor LY; Duke-NUS Medical School, Singapore, Singapore.; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.

المصدر: Cancer communications (London, England) [Cancer Commun (Lond)] 2023 Oct; Vol. 43 (10), pp. 1164-1168. Date of Electronic Publication: 2023 Sep 12.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101723675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2523-3548 (Electronic) Linking ISSN: 25233548 NLM ISO Abbreviation: Cancer Commun (Lond) Subsets: MEDLINE

مواضيع طبية MeSH: East Asian People* , Prostatic Neoplasms*/genetics, Male ; Humans ; Transcriptome ; North America